← Back to Search

E-Cigarette Liquids for Cardiopulmonary Health

N/A

Recruiting

Led By Paula Rodriguez Miguelez, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Non e-cigarette group: 21 years of age or older

E-Cigarette group: 21 years of age or older, Used e-cigarettes (≥3 times/week for ≥3 months)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 2 weeks

Awards & highlights

Study Summary

This trial will study the effects of e-cigarettes on cardiopulmonary health by comparing e-cigarette users to a control group.

Who is the study for?

This trial is for adults over the age of 21 who are either regular e-cigarette users (using them at least three times a week for more than three months) or those who have never used e-cigarettes. It's not specified, but typically people with certain health conditions may be excluded.Check my eligibility

What is being tested?

The study is testing two types of tobacco-flavored liquids used in cartridge-based electronic cigarettes to see how they affect the heart and lungs of the users. Participants will use these liquids and their cardiopulmonary health will be monitored.See study design

What are the potential side effects?

While specific side effects aren't listed, using e-cigarettes can potentially lead to throat irritation, coughing, shortness of breath, and could impact heart rate and blood pressure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 or older and do not use e-cigarettes.

Select...

I am 21 or older and have been using e-cigarettes regularly for at least 3 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Expiratory Volume

Change in Peak oxygen consumption (VO2 peak)

Secondary outcome measures

Change in Maximal microvascular dilation

Change in Skeletal muscle O2 utilization

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: E-cigarette liquid type 1Experimental Treatment1 Intervention

Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.

Group II: E-cigarettes liquid type 2Active Control1 Intervention

Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.

Group III: No e-cigarettesActive Control1 Intervention

No e-cigarette use

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

698 Previous Clinical Trials

22,884,938 Total Patients Enrolled

5 Trials studying Electronic Cigarette Use

192 Patients Enrolled for Electronic Cigarette Use

Paula Rodriguez Miguelez, PhDPrincipal InvestigatorVirginia Commonwealth University

2 Previous Clinical Trials

62 Total Patients Enrolled

Media Library

Tobacco flavored liquid type 1 Clinical Trial Eligibility Overview. Trial Name: NCT05199480 — N/A

Electronic Cigarette Use Research Study Groups: E-cigarette liquid type 1, E-cigarettes liquid type 2, No e-cigarettes

Electronic Cigarette Use Clinical Trial 2023: Tobacco flavored liquid type 1 Highlights & Side Effects. Trial Name: NCT05199480 — N/A

Tobacco flavored liquid type 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT05199480 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can you provide an estimation of the number of individuals currently being admitted to this research trial?

"Yes, the clinicaltrials.gov website confirms that this trial is actively recruiting participants as of February 3rd 2022. The study was first posted on October 10th and seeks 57 volunteers from a single location."

Answered by AI

Does this clinical trial currently have any vacancies?

"As indicated by clinicaltrials.gov, this study is actively seeking participants. This trial was initially advertised on the 10th of January 2022 and its information has been refreshed as recently as 3rd February 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health

2022. "Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05199480.